In a groundbreaking revelation, the Global Rare Gastrointestinal Diseases Treatment Industry, valued at US$1,314.8 million in 2022, is set to undergo a significant transformation with a projected Compound Annual Growth Rate (CAGR) of 3.7% from 2023 to 2033. According to the latest insights by Future Market Insights Inc., this burgeoning industry is expected to reach …